{"count": 39, "results": [{"_id": "36696857", "pmid": 36696857, "title": "Research progress of metformin in the treatment of liver fibrosis.", "journal": "Int Immunopharmacol", "authors": ["Zhang A", "Qian F", "Li Y", "Li B", "Yang F", "Hu C", "Sun W", "Huang Y"], "date": "2023-03-01T00:00:00Z", "doi": "10.1016/j.intimp.2023.109738", "meta_date_publication": "2023 Mar", "meta_volume": "116", "meta_issue": "", "meta_pages": "109738", "score": 50273.742, "text_hl": "Research progress of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in the treatment of @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver fibrosis@@@.", "citations": {"NLM": "Zhang A, Qian F, Li Y, Li B, Yang F, Hu C, Sun W, Huang Y. Research progress of metformin in the treatment of liver fibrosis. Int Immunopharmacol. 2023 Mar;116():109738. PMID: 36696857", "BibTeX": "@article{36696857, title={Research progress of metformin in the treatment of liver fibrosis.}, author={Zhang A and Qian F and Li Y and Li B and Yang F and Hu C and Sun W and Huang Y}, journal={Int Immunopharmacol}, volume={116}, pages={109738}}"}}, {"_id": "38288020", "pmid": 38288020, "pmcid": "PMC10823097", "title": "Metformin exerts anti-liver fibrosis effect based on the regulation of gut microbiota homeostasis and multi-target synergy", "journal": "Heliyon", "authors": ["Kong L", "Ma J", "Dong L", "Zhu C", "Zhang J", "Li J"], "date": "2024-01-12T00:00:00Z", "doi": "10.1016/j.heliyon.2024.e24610", "meta_date_publication": "2024 Jan 30", "meta_volume": "10", "meta_issue": "2", "meta_pages": "e24610", "score": 50269.754, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ exerts anti-@<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver fibrosis@@@ effect based on the regulation of gut microbiota homeostasis and multi-target synergy", "citations": {"NLM": "Kong L, Ma J, Dong L, Zhu C, Zhang J, Li J. Metformin exerts anti-liver fibrosis effect based on the regulation of gut microbiota homeostasis and multi-target synergy Heliyon. 2024 Jan 30;10(2):e24610. PMID: 38288020", "BibTeX": "@article{38288020, title={Metformin exerts anti-liver fibrosis effect based on the regulation of gut microbiota homeostasis and multi-target synergy}, author={Kong L and Ma J and Dong L and Zhu C and Zhang J and Li J}, journal={Heliyon}, volume={10}, number={2}, pages={e24610}}"}}, {"_id": "35344814", "pmid": 35344814, "title": "Mitigation of liver fibrosis via hepatic stellate cells mitochondrial apoptosis induced by metformin.", "journal": "Int Immunopharmacol", "authors": ["Su Y", "Lu S", "Hou C", "Ren K", "Wang M", "Liu X", "Zhao S", "Liu X"], "date": "2022-07-01T00:00:00Z", "doi": "10.1016/j.intimp.2022.108683", "meta_date_publication": "2022 Jul", "meta_volume": "108", "meta_issue": "", "meta_pages": "108683", "score": 50264.492, "text_hl": "Mitigation of @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver fibrosis@@@ via hepatic stellate cells mitochondrial apoptosis induced by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Su Y, Lu S, Hou C, Ren K, Wang M, Liu X, Zhao S, Liu X. Mitigation of liver fibrosis via hepatic stellate cells mitochondrial apoptosis induced by metformin. Int Immunopharmacol. 2022 Jul;108():108683. PMID: 35344814", "BibTeX": "@article{35344814, title={Mitigation of liver fibrosis via hepatic stellate cells mitochondrial apoptosis induced by metformin.}, author={Su Y and Lu S and Hou C and Ren K and Wang M and Liu X and Zhao S and Liu X}, journal={Int Immunopharmacol}, volume={108}, pages={108683}}"}}, {"_id": "36031141", "pmid": 36031141, "pmcid": "PMC10173191", "title": "ANGPTL8 accelerates liver fibrosis mediated by HFD-induced inflammatory activity via LILRB2/ERK signaling pathways", "journal": "J Adv Res", "authors": ["Zhang Z", "Yuan Y", "Hu L", "Tang J", "Meng Z", "Dai L", "Gao Y", "Ma S", "Wang X", "Yuan Y", "Zhang Q", "Cai W", "Ruan X", "Guo X"], "date": "2022-08-27T00:00:00Z", "doi": "10.1016/j.jare.2022.08.006", "meta_date_publication": "2022 Aug 27", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50258.13, "text_hl": "...Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on HFD-induced @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver fibrosis@@@. ", "citations": {"NLM": "Zhang Z, Yuan Y, Hu L, Tang J, Meng Z, Dai L, Gao Y, Ma S, Wang X, Yuan Y, Zhang Q, Cai W, Ruan X, Guo X. ANGPTL8 accelerates liver fibrosis mediated by HFD-induced inflammatory activity via LILRB2/ERK signaling pathways J Adv Res. 2022 Aug 27;():. PMID: 36031141", "BibTeX": "@article{36031141, title={ANGPTL8 accelerates liver fibrosis mediated by HFD-induced inflammatory activity via LILRB2/ERK signaling pathways}, author={Zhang Z and Yuan Y and Hu L and Tang J and Meng Z and Dai L and Gao Y and Ma S and Wang X and Yuan Y and Zhang Q and Cai W and Ruan X and Guo X}, journal={J Adv Res}}"}}, {"_id": "36893671", "pmid": 36893671, "title": "Metformin alleviates liver fibrosis in mice by enriching Lactobacillus sp. MF-1 in the gut microbiota.", "journal": "Biochim Biophys Acta Mol Basis Dis", "authors": ["Yang T", "Guan Q", "Shi JS", "Xu ZH", "Geng Y"], "date": "2023-03-07T00:00:00Z", "doi": "10.1016/j.bbadis.2023.166664", "meta_date_publication": "2023 Mar 7", "meta_volume": "1869", "meta_issue": "5", "meta_pages": "166664", "score": 50257.35, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ alleviates @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver fibrosis@@@ in @SPECIES_10090 @@@mice@@@ by enriching @SPECIES_1591 @@@Lactobacillus sp.@@@ MF-1 in the gut microbiota.", "citations": {"NLM": "Yang T, Guan Q, Shi JS, Xu ZH, Geng Y. Metformin alleviates liver fibrosis in mice by enriching Lactobacillus sp. MF-1 in the gut microbiota. Biochim Biophys Acta Mol Basis Dis. 2023 Mar 7;1869(5):166664. PMID: 36893671", "BibTeX": "@article{36893671, title={Metformin alleviates liver fibrosis in mice by enriching Lactobacillus sp. MF-1 in the gut microbiota.}, author={Yang T and Guan Q and Shi JS and Xu ZH and Geng Y}, journal={Biochim Biophys Acta Mol Basis Dis}, volume={1869}, number={5}, pages={166664}}"}}, {"_id": "34198358", "pmid": 34198358, "pmcid": "PMC9292486", "title": "Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis", "journal": "Br J Clin Pharmacol", "authors": ["Yen FS", "Huang YH", "Hou MC", "Hwu CM", "Lo YR", "Shin SJ", "Hsu CC"], "date": "2022-01-01T00:00:00Z", "doi": "10.1111/bcp.14970", "meta_date_publication": "2022 Jan", "meta_volume": "88", "meta_issue": "1", "meta_pages": "311-322", "score": 50256.727, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ use and @DISEASE_Idiopathic_Noncirrhotic_Portal_Hypertension @DISEASE_MESH:D000094724 @@@cirrhotic@@@ decompensation in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ and @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver cirrhosis@@@", "citations": {"NLM": "Yen FS, Huang YH, Hou MC, Hwu CM, Lo YR, Shin SJ, Hsu CC. Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis Br J Clin Pharmacol. 2022 Jan;88(1):311-322. PMID: 34198358", "BibTeX": "@article{34198358, title={Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis}, author={Yen FS and Huang YH and Hou MC and Hwu CM and Lo YR and Shin SJ and Hsu CC}, journal={Br J Clin Pharmacol}, volume={88}, number={1}, pages={311-322}}"}}, {"_id": "37451514", "pmid": 37451514, "title": "Metformin ameliorates liver fibrosis induced by congestive hepatopathy via the mTOR/HIF-1alpha signaling pathway.", "journal": "Ann Hepatol", "authors": ["Yang J", "Li S", "Liu S", "Zhang Y", "Shen D", "Wang P", "Dang X"], "date": "2023-07-12T00:00:00Z", "doi": "10.1016/j.aohep.2023.101135", "meta_date_publication": "2023 Jul 12", "meta_volume": "", "meta_issue": "", "meta_pages": "101135", "score": 50254.414, "text_hl": "However, the function of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@congestive liver fibrosis@@@ is not yet fully understood. ", "citations": {"NLM": "Yang J, Li S, Liu S, Zhang Y, Shen D, Wang P, Dang X. Metformin ameliorates liver fibrosis induced by congestive hepatopathy via the mTOR/HIF-1alpha signaling pathway. Ann Hepatol. 2023 Jul 12;():101135. PMID: 37451514", "BibTeX": "@article{37451514, title={Metformin ameliorates liver fibrosis induced by congestive hepatopathy via the mTOR/HIF-1alpha signaling pathway.}, author={Yang J and Li S and Liu S and Zhang Y and Shen D and Wang P and Dang X}, journal={Ann Hepatol}, pages={101135}}"}}, {"_id": "36474458", "pmid": 36474458, "title": "Metformin: new applications for an old drug.", "journal": "J Basic Clin Physiol Pharmacol", "authors": ["Naseri A", "Sanaie S", "Hamzehzadeh S", "Seyedi-Sahebari S", "Hosseini MS", "Gholipour-Khalili E", "Rezazadeh-Gavgani E", "Majidazar R", "Seraji P", "Daneshvar S", "Rezazadeh-Gavgani E"], "date": "2022-12-07T00:00:00Z", "doi": "10.1515/jbcpp-2022-0252", "meta_date_publication": "2022 Dec 7", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50254.367, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ decreased the risk of @DISEASE_Death @DISEASE_MESH:D003643 @@@death@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver cirrhosis@@@. ", "citations": {"NLM": "Naseri A, Sanaie S, Hamzehzadeh S, Seyedi-Sahebari S, Hosseini MS, Gholipour-Khalili E, Rezazadeh-Gavgani E, Majidazar R, Seraji P, Daneshvar S, Rezazadeh-Gavgani E. Metformin: new applications for an old drug. J Basic Clin Physiol Pharmacol. 2022 Dec 7;():. PMID: 36474458", "BibTeX": "@article{36474458, title={Metformin: new applications for an old drug.}, author={Naseri A and Sanaie S and Hamzehzadeh S and Seyedi-Sahebari S and Hosseini MS and Gholipour-Khalili E and Rezazadeh-Gavgani E and Majidazar R and Seraji P and Daneshvar S and Rezazadeh-Gavgani E}, journal={J Basic Clin Physiol Pharmacol}}"}}, {"_id": "36716817", "pmid": 36716817, "title": "Metformin induces mitochondrial fission and reduces energy metabolism by targeting respiratory chain complex I in hepatic stellate cells to reverse liver fibrosis.", "journal": "Int J Biochem Cell Biol", "authors": ["Su Y", "Hou C", "Wang M", "Ren K", "Zhou D", "Liu X", "Zhao S", "Liu X"], "date": "2023-04-01T00:00:00Z", "doi": "10.1016/j.biocel.2023.106375", "meta_date_publication": "2023 Apr", "meta_volume": "157", "meta_issue": "", "meta_pages": "106375", "score": 50253.953, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ induces mitochondrial fission and reduces energy metabolism by targeting respiratory chain complex I in hepatic stellate cells to reverse @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver fibrosis@@@.", "citations": {"NLM": "Su Y, Hou C, Wang M, Ren K, Zhou D, Liu X, Zhao S, Liu X. Metformin induces mitochondrial fission and reduces energy metabolism by targeting respiratory chain complex I in hepatic stellate cells to reverse liver fibrosis. Int J Biochem Cell Biol. 2023 Apr;157():106375. PMID: 36716817", "BibTeX": "@article{36716817, title={Metformin induces mitochondrial fission and reduces energy metabolism by targeting respiratory chain complex I in hepatic stellate cells to reverse liver fibrosis.}, author={Su Y and Hou C and Wang M and Ren K and Zhou D and Liu X and Zhao S and Liu X}, journal={Int J Biochem Cell Biol}, volume={157}, pages={106375}}"}}, {"_id": "35093389", "pmid": 35093389, "title": "Metformin versus silymarin as hepatoprotective agents in mice fibrotic model caused by carbon tetrachloride.", "journal": "Ann Pharm Fr", "authors": ["Omar ZMM", "Ahmed AA", "El-Bakry MH", "Ahmed MA", "Hasan A"], "date": "2022-09-01T00:00:00Z", "doi": "10.1016/j.pharma.2022.01.005", "meta_date_publication": "2022 Sep", "meta_volume": "80", "meta_issue": "5", "meta_pages": "659-668", "score": 50253.902, "text_hl": "OBJECTIVES: To study @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ hepatoprotective effects compared to @CHEMICAL_Silymarin @CHEMICAL_MESH:D012838 @@@silymarin@@@ on @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@hepatic fibrosis@@@ caused by @CHEMICAL_Carbon_Tetrachloride @CHEMICAL_MESH:D002251 @@@carbon tetrachloride@@@ (@CHEMICAL_Carbon_Tetrachloride @CHEMICAL_MESH:D002251 @@@CCl4@@@) in @SPECIES_10090 @@@mice@@@. ", "citations": {"NLM": "Omar ZMM, Ahmed AA, El-Bakry MH, Ahmed MA, Hasan A. Metformin versus silymarin as hepatoprotective agents in mice fibrotic model caused by carbon tetrachloride. Ann Pharm Fr. 2022 Sep;80(5):659-668. PMID: 35093389", "BibTeX": "@article{35093389, title={Metformin versus silymarin as hepatoprotective agents in mice fibrotic model caused by carbon tetrachloride.}, author={Omar ZMM and Ahmed AA and El-Bakry MH and Ahmed MA and Hasan A}, journal={Ann Pharm Fr}, volume={80}, number={5}, pages={659-668}}"}}]}